Detalhe da pesquisa
1.
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer.
Oncologist
; 28(2): 123-130, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495309
2.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825569
3.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589839
4.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
J Natl Compr Canc Netw
; 21(6): 594-608, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308117
5.
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 380(8): 741-751, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786188
6.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608580
7.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Breast Cancer Res Treat
; 187(1): 155-165, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591468
8.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120223
9.
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer.
Int J Mol Sci
; 22(10)2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34069042
10.
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Breast Cancer Res Treat
; 184(2): 357-364, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767201
11.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32378051
12.
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.
Breast Cancer Res
; 21(1): 78, 2019 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277699
13.
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer.
Breast Cancer Res Treat
; 178(1): 121-133, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368034
14.
A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
Ann Surg Oncol
; 26(10): 3250-3259, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054038
15.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast Cancer Res Treat
; 171(3): 637-648, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938395
16.
Surgical Findings and Outcomes in Premenopausal Breast Cancer Patients Undergoing Oophorectomy: A Multicenter Review From the Society of Gynecologic Surgeons Fellows Pelvic Research Network.
J Minim Invasive Gynecol
; 25(1): 111-115, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821472
17.
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Eur J Nucl Med Mol Imaging
; 43(13): 2374-2380, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557845
18.
Subtyping of triple-negative breast cancer: implications for therapy.
Cancer
; 121(1): 8-16, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043972
19.
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Oncologist
; 19(6): 616-22, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797823
20.
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
Breast Cancer Res Treat
; 145(2): 389-99, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24722917